Pages that link to "Q53611612"

The following pages link to Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response. (Q53611612):

Displaying 22 items.

• Role of the tumor microenvironment in mature B-cell lymphoid malignancies (Q26748775) (← links)
• Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meeting (Q28075816) (← links)
• Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy (Q33606111) (← links)
• Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer (Q34270064) (← links)
• The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. (Q35052176) (← links)
• B7-h1 expressed by activated CD8 T cells is essential for their survival. (Q35566744) (← links)
• Hepatoma cells up-regulate expression of programmed cell death-1 on T cells (Q37413288) (← links)
• Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections (Q37474904) (← links)
• Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy (Q37656305) (← links)
• Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4 T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen (Q37740679) (← links)
• Therapeutic targeting of B7-H1 in breast cancer. (Q37922793) (← links)
• Breakthrough therapies in B-cell non-Hodgkin lymphoma. (Q38708600) (← links)
• Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies (Q38851114) (← links)
• Involvement of ERK and JNK pathways in IFN-γ-induced B7-DC expression on tumor cells (Q39715037) (← links)
• Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs. (Q46632481) (← links)
• PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response? (Q47120629) (← links)
• PD-1 expression and clinical PD-1 blockade in B-cell lymphomas (Q47424027) (← links)
• Anti‐PD‐1 synergizes with cyclophosphamide to induce potent anti‐tumor vaccine effects through novel mechanisms (Q84459533) (← links)
• Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B (Q84596995) (← links)
• B7-DC-Ig enhances vaccine effect by a novel mechanism dependent on PD-1 expression level on T cell subsets (Q84633735) (← links)
• PD-L1 Expression and Tumor-infiltrating Lymphocytes in Breast Cancer: Clinicopathological Analysis in Women Younger than 40 Years Old (Q89947329) (← links)
• The expression of PD-L1 in salivary gland carcinomas (Q93106859) (← links)